Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1969 1
1970 2
1971 2
1972 2
1974 1
1975 2
1976 1
1977 2
1978 2
1979 1
1981 1
1983 2
1984 1
1989 4
1990 2
1991 5
1992 1
1994 10
1996 4
1997 5
1998 1
1999 1
2001 1
2002 1
2003 2
2004 5
2005 6
2006 8
2007 3
2008 8
2009 4
2010 6
2011 7
2012 10
2013 13
2014 13
2015 15
2016 10
2017 18
2018 17
2019 26
2020 32
2021 46
2022 34
2023 36
2024 13

Text availability

Article attribute

Article type

Publication date

Search Results

351 results

Results by year

Filters applied: . Clear all
Page 1
Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS.
Miller TM, Cudkowicz ME, Genge A, Shaw PJ, Sobue G, Bucelli RC, Chiò A, Van Damme P, Ludolph AC, Glass JD, Andrews JA, Babu S, Benatar M, McDermott CJ, Cochrane T, Chary S, Chew S, Zhu H, Wu F, Nestorov I, Graham D, Sun P, McNeill M, Fanning L, Ferguson TA, Fradette S; VALOR and OLE Working Group. Miller TM, et al. N Engl J Med. 2022 Sep 22;387(12):1099-1110. doi: 10.1056/NEJMoa2204705. N Engl J Med. 2022. PMID: 36129998 Free article. Clinical Trial.
Dynamic landscape of immune cell-specific gene regulation in immune-mediated diseases.
Ota M, Nagafuchi Y, Hatano H, Ishigaki K, Terao C, Takeshima Y, Yanaoka H, Kobayashi S, Okubo M, Shirai H, Sugimori Y, Maeda J, Nakano M, Yamada S, Yoshida R, Tsuchiya H, Tsuchida Y, Akizuki S, Yoshifuji H, Ohmura K, Mimori T, Yoshida K, Kurosaka D, Okada M, Setoguchi K, Kaneko H, Ban N, Yabuki N, Matsuki K, Mutoh H, Oyama S, Okazaki M, Tsunoda H, Iwasaki Y, Sumitomo S, Shoda H, Kochi Y, Okada Y, Yamamoto K, Okamura T, Fujio K. Ota M, et al. Among authors: oyama s. Cell. 2021 May 27;184(11):3006-3021.e17. doi: 10.1016/j.cell.2021.03.056. Epub 2021 May 1. Cell. 2021. PMID: 33930287 Free article.
Colorectal cancer in Crohn's disease: a series of 6 cases.
Ishimaru K, Tominaga T, Nonaka T, Fukuda A, Moriyama M, Oyama S, Ishii M, Sawai T, Nagayasu T. Ishimaru K, et al. Among authors: oyama s. Surg Case Rep. 2021 Jun 28;7(1):152. doi: 10.1186/s40792-021-01237-0. Surg Case Rep. 2021. PMID: 34181132 Free PMC article.
A New Potential Therapeutic Target for Cancer in Ubiquitin-Like Proteins-UBL3.
Zhang H, Chen B, Waliullah ASM, Aramaki S, Ping Y, Takanashi Y, Zhang C, Zhai Q, Yan J, Oyama S, Kahyo T, Setou M. Zhang H, et al. Among authors: oyama s. Int J Mol Sci. 2023 Jan 8;24(2):1231. doi: 10.3390/ijms24021231. Int J Mol Sci. 2023. PMID: 36674743 Free PMC article. Review.
Drug-induced Neuropsychiatric Adverse Events Using Post-Marketing Surveillance.
Wakabayashi T, Nakatsuji T, Kambara H, Niinomi I, Oyama S, Inada A, Ueno S, Uchida M, Iwanaga K, Iida T, Hosohata K. Wakabayashi T, et al. Among authors: oyama s. Curr Rev Clin Exp Pharmacol. 2022;17(2):144-148. doi: 10.2174/1574884716666210215104540. Curr Rev Clin Exp Pharmacol. 2022. PMID: 33588740 Free PMC article.
Use of in-Hospital Geomagnetic Fingerprinting Localization.
Yamashita K, Oyama S, Otani T, Yamashita S, Furukawa T, Kobayashi D, Sato K, Sugano A, Funada C, Mori K, Shiratori Y. Yamashita K, et al. Among authors: oyama s. Stud Health Technol Inform. 2019 Aug 21;264:2007-2008. doi: 10.3233/SHTI190758. Stud Health Technol Inform. 2019. PMID: 31438452
Epigenetics and Racial Health Inequities.
Oyama S, Terry SF. Oyama S, et al. Genet Test Mol Biomarkers. 2016 Sep;20(9):483-4. doi: 10.1089/gtmb.2016.29021.sjt. Genet Test Mol Biomarkers. 2016. PMID: 27636025 No abstract available.
351 results